Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

SNDA vs DBVT vs ENSG vs ALKS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SNDA
Sonida Senior Living, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$695M
5Y Perf.+269.5%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-58.8%
ENSG
The Ensign Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$10.18B
5Y Perf.+298.7%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+116.4%

SNDA vs DBVT vs ENSG vs ALKS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SNDA logoSNDA
DBVT logoDBVT
ENSG logoENSG
ALKS logoALKS
IndustryMedical - Care FacilitiesBiotechnologyMedical - Care FacilitiesBiotechnology
Market Cap$695M$1712.35T$10.18B$5.90B
Revenue (TTM)$381M$0.00$5.27B$1.56B
Net Income (TTM)$-71M$-168M$363M$153M
Gross Margin-8.0%15.2%65.4%
Operating Margin-15.3%8.5%12.3%
Forward P/E23.2x24.8x
Total Debt$690M$22M$4.15B$70M
Cash & Equiv.$11M$194M$504M$1.12B

SNDA vs DBVT vs ENSG vs ALKSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SNDA
DBVT
ENSG
ALKS
StockMay 20May 26Return
Sonida Senior Livin… (SNDA)100369.5+269.5%
DBV Technologies S.… (DBVT)10041.2-58.8%
The Ensign Group, I… (ENSG)100398.7+298.7%
Alkermes plc (ALKS)100216.4+116.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: SNDA vs DBVT vs ENSG vs ALKS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ENSG leads in 3 of 7 categories, making it the strongest pick for valuation and capital efficiency and capital preservation and lower volatility. Sonida Senior Living, Inc. is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. DBVT and ALKS also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
SNDA
Sonida Senior Living, Inc.
The Growth Leader

SNDA is the #2 pick in this set and the best alternative if growth and dividends is your priority.

  • 25.2% revenue growth vs DBVT's -100.0%
  • 0.9% yield, 1-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend)
Best for: growth and dividends
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT is the clearest fit if your priority is momentum.

  • +110.4% vs ALKS's +16.5%
Best for: momentum
ENSG
The Ensign Group, Inc.
The Income Pick

ENSG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 12 yrs, beta 0.42, yield 0.1%
  • Rev growth 18.7%, EPS growth 14.1%, 3Y rev CAGR 18.7%
  • 7.5% 10Y total return vs ALKS's -11.0%
  • Beta 0.42, yield 0.1%, current ratio 1.42x
Best for: income & stability and growth exposure
ALKS
Alkermes plc
The Defensive Pick

ALKS is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • 9.8% margin vs SNDA's -18.7%
Best for: sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthSNDA logoSNDA25.2% revenue growth vs DBVT's -100.0%
ValueENSG logoENSGBetter valuation composite
Quality / MarginsALKS logoALKS9.8% margin vs SNDA's -18.7%
Stability / SafetyENSG logoENSGBeta 0.42 vs DBVT's 1.26
DividendsSNDA logoSNDA0.9% yield, 1-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend)
Momentum (1Y)DBVT logoDBVT+110.4% vs ALKS's +16.5%
Efficiency (ROA)ENSG logoENSG6.8% ROA vs DBVT's -89.0%

SNDA vs DBVT vs ENSG vs ALKS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SNDASonida Senior Living, Inc.
FY 2024
Health Care, Resident Service
46.8%$268M
Housing And Support Services
46.3%$265M
Community Reimbursement Revenue
5.8%$33M
Management Service
0.6%$3M
Community Fees
0.3%$2M
Ancillary Services
0.2%$1M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ENSGThe Ensign Group, Inc.
FY 2025
Skilled Services Segment
97.4%$4.8B
Standard Bearer Segment
2.6%$127M
ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M

SNDA vs DBVT vs ENSG vs ALKS — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGENSG

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 5 of 6 comparable metrics.

ENSG and DBVT operate at a comparable scale, with $5.3B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to SNDA's -18.7%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSNDA logoSNDASonida Senior Liv…DBVT logoDBVTDBV Technologies …ENSG logoENSGThe Ensign Group,…ALKS logoALKSAlkermes plc
RevenueTrailing 12 months$381M$0$5.3B$1.6B
EBITDAEarnings before interest/tax-$1M-$112M$558M$212M
Net IncomeAfter-tax profit-$71M-$168M$363M$153M
Free Cash FlowCash after capex-$9M-$151M$406M$392M
Gross MarginGross profit ÷ Revenue-8.0%+15.2%+65.4%
Operating MarginEBIT ÷ Revenue-15.3%+8.5%+12.3%
Net MarginNet income ÷ Revenue-18.7%+6.9%+9.8%
FCF MarginFCF ÷ Revenue-2.3%+7.7%+25.1%
Rev. Growth (YoY)Latest quarter vs prior year+6.2%+18.4%+28.2%
EPS Growth (YoY)Latest quarter vs prior year-3.5%+91.5%+21.9%-4.1%
ALKS leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

Evenly matched — SNDA and ALKS each lead in 2 of 5 comparable metrics.

At 24.8x trailing earnings, ALKS trades at a 17% valuation discount to ENSG's 29.8x P/E. On an enterprise value basis, ALKS's 17.3x EV/EBITDA is more attractive than ENSG's 25.7x.

MetricSNDA logoSNDASonida Senior Liv…DBVT logoDBVTDBV Technologies …ENSG logoENSGThe Ensign Group,…ALKS logoALKSAlkermes plc
Market CapShares × price$695M$1712.35T$10.2B$5.9B
Enterprise ValueMkt cap + debt − cash$1.4B$1712.35T$13.8B$4.9B
Trailing P/EPrice ÷ TTM EPS-8.67x-0.76x29.85x24.76x
Forward P/EPrice ÷ next-FY EPS est.23.19x
PEG RatioP/E ÷ EPS growth rate2.16x
EV / EBITDAEnterprise value multiple25.71x17.25x
Price / SalesMarket cap ÷ Revenue1.82x2.01x4.00x
Price / BookPrice ÷ Book value/share11.76x0.66x4.59x3.28x
Price / FCFMarket cap ÷ FCF27.46x12.28x
Evenly matched — SNDA and ALKS each lead in 2 of 5 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 5 of 9 comparable metrics.

ENSG delivers a 16.6% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNDA's 12.26x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs SNDA's 3/9, reflecting strong financial health.

MetricSNDA logoSNDASonida Senior Liv…DBVT logoDBVTDBV Technologies …ENSG logoENSGThe Ensign Group,…ALKS logoALKSAlkermes plc
ROE (TTM)Return on equity-76.4%-130.2%+16.6%+8.8%
ROA (TTM)Return on assets-8.4%-89.0%+6.8%+5.4%
ROICReturn on invested capital-5.8%+7.0%+18.9%
ROCEReturn on capital employed-7.7%-145.7%+10.2%+14.2%
Piotroski ScoreFundamental quality 0–93457
Debt / EquityFinancial leverage12.26x0.13x1.86x0.04x
Net DebtTotal debt minus cash$679M-$172M$3.7B-$1.0B
Cash & Equiv.Liquid assets$11M$194M$504M$1.1B
Total DebtShort + long-term debt$690M$22M$4.2B$70M
Interest CoverageEBIT ÷ Interest expense-0.86x-189.82x88.33x32.30x
ALKS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — SNDA and ENSG each lead in 2 of 6 comparable metrics.

A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs ALKS's +16.5%. The 3-year compound annual growth rate (CAGR) favors SNDA at 73.9% vs ALKS's 4.6% — a key indicator of consistent wealth creation.

MetricSNDA logoSNDASonida Senior Liv…DBVT logoDBVTDBV Technologies …ENSG logoENSGThe Ensign Group,…ALKS logoALKSAlkermes plc
YTD ReturnYear-to-date+14.6%+4.9%+0.3%+25.3%
1-Year ReturnPast 12 months+52.7%+110.4%+27.5%+16.5%
3-Year ReturnCumulative with dividends+426.3%+19.7%+88.9%+14.5%
5-Year ReturnCumulative with dividends-23.8%-69.1%+103.2%+60.9%
10-Year ReturnCumulative with dividends-87.7%-87.0%+752.0%-11.0%
CAGR (3Y)Annualised 3-year return+73.9%+6.2%+23.6%+4.6%
Evenly matched — SNDA and ENSG each lead in 2 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ENSG and ALKS each lead in 1 of 2 comparable metrics.

ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs DBVT's 76.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSNDA logoSNDASonida Senior Liv…DBVT logoDBVTDBV Technologies …ENSG logoENSGThe Ensign Group,…ALKS logoALKSAlkermes plc
Beta (5Y)Sensitivity to S&P 5001.10x1.26x0.42x1.06x
52-Week HighHighest price in past year$38.98$26.18$218.00$36.60
52-Week LowLowest price in past year$23.53$7.53$133.81$25.17
% of 52W HighCurrent price vs 52-week peak+93.8%+76.3%+80.0%+96.7%
RSI (14)Momentum oscillator 0–10063.548.123.360.2
Avg Volume (50D)Average daily shares traded602K252K358K2.3M
Evenly matched — ENSG and ALKS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — SNDA and ENSG each lead in 1 of 2 comparable metrics.

Analyst consensus: SNDA as "Hold", DBVT as "Buy", ENSG as "Buy", ALKS as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs -5.2% for SNDA (target: $35). For income investors, SNDA offers the higher dividend yield at 0.85% vs ENSG's 0.14%.

MetricSNDA logoSNDASonida Senior Liv…DBVT logoDBVTDBV Technologies …ENSG logoENSGThe Ensign Group,…ALKS logoALKSAlkermes plc
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuy
Price TargetConsensus 12-month target$34.67$46.33$222.33$44.00
# AnalystsCovering analysts3151328
Dividend YieldAnnual dividend ÷ price+0.9%+0.1%
Dividend StreakConsecutive years of raises10120
Dividend / ShareAnnual DPS$0.31$0.24
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.2%+0.5%
Evenly matched — SNDA and ENSG each lead in 1 of 2 comparable metrics.
Key Takeaway

ALKS leads in 2 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 4 categories are tied.

Best OverallAlkermes plc (ALKS)Leads 2 of 6 categories
Loading custom metrics...

SNDA vs DBVT vs ENSG vs ALKS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SNDA or DBVT or ENSG or ALKS a better buy right now?

For growth investors, Sonida Senior Living, Inc.

(SNDA) is the stronger pick with 25. 2% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SNDA or DBVT or ENSG or ALKS?

On trailing P/E, Alkermes plc (ALKS) is the cheapest at 24.

8x versus The Ensign Group, Inc. at 29. 8x.

03

Which is the better long-term investment — SNDA or DBVT or ENSG or ALKS?

Over the past 5 years, The Ensign Group, Inc.

(ENSG) delivered a total return of +103. 2%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus SNDA's -87. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SNDA or DBVT or ENSG or ALKS?

By beta (market sensitivity over 5 years), The Ensign Group, Inc.

(ENSG) is the lower-risk stock at 0. 42β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 198% more volatile than ENSG relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 12% for Sonida Senior Living, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — SNDA or DBVT or ENSG or ALKS?

By revenue growth (latest reported year), Sonida Senior Living, Inc.

(SNDA) is pulling ahead at 25. 2% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: The Ensign Group, Inc. grew EPS 14. 1% year-over-year, compared to -681. 5% for Sonida Senior Living, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SNDA or DBVT or ENSG or ALKS?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -20. 0% for Sonida Senior Living, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -15. 3% for SNDA. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SNDA or DBVT or ENSG or ALKS more undervalued right now?

Analyst consensus price targets imply the most upside for DBVT: 131.

8% to $46. 33.

08

Which pays a better dividend — SNDA or DBVT or ENSG or ALKS?

In this comparison, SNDA (0.

9% yield), ENSG (0. 1% yield) pay a dividend. DBVT, ALKS do not pay a meaningful dividend and should not be held primarily for income.

09

Is SNDA or DBVT or ENSG or ALKS better for a retirement portfolio?

For long-horizon retirement investors, The Ensign Group, Inc.

(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +752. 0% 10Y return). Both have compounded well over 10 years (ENSG: +752. 0%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SNDA and DBVT and ENSG and ALKS?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SNDA is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; ENSG is a mid-cap high-growth stock; ALKS is a small-cap quality compounder stock. SNDA pays a dividend while DBVT, ENSG, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SNDA

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ENSG

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Net Margin > 5%
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.